Study to Evaluate the Effects of 90 mg Intravenous Infusions of GC4419 on the Single Dose Pharmacokinetics of Dextromethorphan in Healthy Adult Subjects
Clinical trial NCT03792971 · COMPLETED
Trial details
- NCT number
- NCT03792971
- Sponsor
- Galera Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-10
- Primary completion
- 2019-02-15
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.